SCHEMBL2365885

SCHEMBL2365885

COCC1COC(=O)N1c1ccc(C(=O)N2CCN(c3ncc(C)cc3C)CC2)c(N2CCCS2(=O)=O)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.35
LMNA P02545 7/20 0.35
TP53 P04637 6/20 0.35
MAPT P10636 2/20 0.35
PIK3C3 Q8NEB9 1/20 0.33
SLC6A9 P48067 1/20 0.33
SLC6A5 Q9Y345 1/20 0.33
KIF18A Q8NI77 1/20 0.32
THRB P10828 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CFTR P13569 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
HPGD P15428 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31
IDH1 O75874 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2365877 1.00 PIK3CA (0.35) PIK3CALMNATP53MAPTPIK3C3
SCHEMBL2366149 0.93 LMNA (0.36) LMNATP53MAPTPIK3C3SLC6A9
SCHEMBL2366156 0.93 LMNA (0.36) LMNATP53MAPTPIK3C3SLC6A9
SCHEMBL2366804 0.92 PIK3CA (0.34) PIK3CALMNATP53MAPTPIK3C3
SCHEMBL2366811 0.92 PIK3CA (0.34) PIK3CALMNATP53MAPTPIK3C3
SCHEMBL12240542 0.92 P2RX3 (0.37) LMNATP53MAPTPIK3C3SLC6A9
SCHEMBL2365865 0.92 PIK3CA (0.35) PIK3CALMNATP53MAPTPIK3C3
SCHEMBL2365874 0.92 PIK3CA (0.35) PIK3CALMNATP53MAPTPIK3C3
Hydrochloric Acid SCHEMBL2365808 0.91 P2RX3 (0.36) LMNATP53MAPTPIK3C3SLC6A9
Hydrochloric Acid SCHEMBL2365798 0.91 P2RX3 (0.36) LMNATP53MAPTPIK3C3SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364975-B1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MITSUBISHI TANABE PHARMA CORP (JP) 2013-06-12 EP disclosed
US-8354401-B2 Oxazolidinone amide aromatic compounds for supressing MMP-9 production MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-01-15 US disclosed
US-20110263571-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-10-27 US disclosed
EP-2364975-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE Mitsubishi Tanabe Pharma Corporation (JP) 2011-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263571-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MMP9, MMP10, MMP2 PIK3CA 4648/4885LMNA 3668/4885TP53 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.